Ventas (VTR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
14 May, 2026Opening remarks and agenda
Meeting materials, agenda, and rules of conduct were made available electronically to all participants.
The meeting was officially called to order by the Chairman and CEO, with introductions of directors, executive officers, and the independent auditor.
Attendees were reminded that the meeting was being recorded and that forward-looking statements may be discussed.
Board and executive committee updates
The board and executive officers were introduced, including the Chairman/CEO, CFO, and other key leaders.
Shareholder proposals
No shareholder proposals or director nominations were received in advance; only board-nominated proposals were considered.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Ventas
- Secular demand, platform scale, and acquisitions drive multi-year NOI and value creation.VTR
47th Annual Raymond James Institutional Investor Conference29 Apr 2026 - Double-digit SHOP growth, $5.5B liquidity, and $3B investment guidance highlight Q1 momentum.VTR
Q1 202628 Apr 2026 - Director elections, executive pay, and auditor ratification up for virtual shareholder vote.VTR
Proxy filing1 Apr 2026 - TSR topped 35% in 2025, with strong governance, pay-for-performance, and ESG focus.VTR
Proxy filing1 Apr 2026 - Senior housing growth accelerates with strong demand, limited supply, and data-driven execution.VTR
Citi’s Miami Global Property CEO Conference 20263 Mar 2026 - 2026 outlook projects 8% Normalized FFO growth, led by strong senior housing performance.VTR
Investor presentation2 Mar 2026 - 2025 saw double-digit SHOP NOI and FFO growth, a raised dividend, and $2.5B in investments.VTR
Q4 20256 Feb 2026 - 2025 growth outlook raised as strong demand, pricing power, and investments drive robust performance.VTR
Nareit REITweek: 2025 Investor Conference3 Feb 2026 - Q2 2024 FFO per share up 7% on strong senior housing; guidance and investments increased.VTR
Q2 20242 Feb 2026